Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Results 661-680 of 1,169,652 for in 'Dáil debates' OR (speaker:Paul Gavan OR speaker:Hildegarde Naughton OR speaker:Kieran O'Donnell OR speaker:Seán Canney OR speaker:Seán Fleming OR speaker:Seán Sherlock OR speaker:Francis Noel Duffy OR speaker:Richard Bruton OR speaker:Richard Bruton6 OR speaker:Leo Varadkar OR speaker:Brendan Griffin OR speaker:Marian Harkin OR speaker:Stephen Donnelly OR speaker:Éamon Ó Cuív OR speaker:Paul Donnelly OR speaker:Matt Shanahan OR speaker:Richard Boyd Barrett OR speaker:Éamon Ó Cuív88 OR speaker:Duncan Smith OR speaker:Aindrias Moynihan OR speaker:Pa Daly OR speaker:Martin Browne OR speaker:Darren O'Rourke OR speaker:Peadar Tóibín OR speaker:Éamon Ó Cuív00 OR speaker:Patricia Ryan OR speaker:Colm Burke OR speaker:Joe O'Brien OR speaker:Éamon Ó Cuív14 OR speaker:Niall Collins OR speaker:Heather Humphreys OR speaker:Damien English OR speaker:Gino Kenny OR speaker:Patrick Costello OR speaker:Neasa Hourigan OR speaker:James Lawless OR speaker:Donnchadh Ó Laoghaire OR speaker:Gerald Nash OR speaker:Bríd Smith OR speaker:Paul McAuliffe OR speaker:Seán Haughey OR speaker:Mick Barry OR speaker:John Lahart OR speaker:Éamon Ó Cuív11) in 'Committee meetings'

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Matt Shanahan: Would any other speaker like to take that on as well?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Matt Shanahan: I want to ask both witnesses about monitoring. Dr. Kelly referenced a high level document he was not allowed to contribute to because the HSE was the lead agency evaluating all of this. What awareness do the witnesses have of the monitoring of their efficiency metrics in the system in order to understand where they are going in getting patients through the system, the waiting times and the...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I welcome our witnesses. I want to touch on stigma but before that I will go back to nurse prescribing. A lot of the discussion we are having today reminds me of when I followed the nurse prescribing journey in diabetes. It reminds me of that a lot, in that it is a lifestyle-based treatment and is very much about who you meet when you go into a clinic. At the front line that is often...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I presume we should have non-elective modules within training for all medical professionals. Would that be specifically on addiction or would it be more useful for it be about what trauma-centred care looks like?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Would the other witnesses like to come in on addiction versus trauma led?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: The research suggests that when you are on the front line, those attitudes become more prevalent.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: That would take care of all of our new cohort. There are hundreds of thousands of people working in services that are central or tangential to our health service. How do we hit all of them? Do we need to get everybody into a continuing professional development course on addiction and trauma-like care?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: How far along are we on that journey?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Working in an emergency department is different from working in a laboratory.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I will return to the question of the inspection of services. I am a member of the Joint Committee on Health, where we talk a lot about the inspection side of things in the context of oversight, performance indicators and outcomes. Who would do that? Perhaps that is not fair. What kind of a body could the witnesses imagine undertaking that piece of work?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Could Dr. Kelly give me an idea of the breadth and level of that service? Would it include all the third-party and NGO services?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Would it influence how drug task forces work?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: It is crazy.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: By proxy, there would be a benchmark that you could fall below and therefore-----

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I have a question about data which struck me when talking about the prisons. I was reading something about it. Do we have the data about how many persons are eligible for OST or who would be appropriate for OST? Not somebody who has tried a drug once, but somebody who would benefit from OST. How many are actually in treatment? One statistic I read stated 35% of people who should be in...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Yes, of course. To be honest, my question was not just what the number is but whether we are recording the data. When I ask a question about health, I am often told it is not recorded. As a result, I was wondering whether we have a sense of the data.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Why is that?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Gino Kenny: I welcome our guests to the third module of our discussion on a health-led approach to drugs policy. From An Garda Síochána, I welcome Deputy Commissioner Justin Kelly. I congratulate Mr. Kelly on his promotion. I also welcome Detective Chief Superintendent Séamus Boland, who is with the national Garda National Drugs and Organised Crime Bureau. The witnesses are very...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Gino Kenny: I thank Mr. Kelly.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Gino Kenny: The next speaker is Deputy Ward.

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person